CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company") today released a letter to shareholders from the Chairman of the Company's Board ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

CytoMed has generated the critical cell banks for the iPSC-derived hybrid of gamma delta T and Natural Killer cell technology and is currently undergoing process development into a potentially very ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

How a radical surgical approach saved the life of a neonatal nurse practitioner with a rare abdominal cancer - but meant ...

Yet, uptake levels of vaccines in the US would tell a different story. As of mid-December, only 20.9 percent of adults in the ...

Maersk on Thursday said it expects to grow its business to track an expected 4% growth in container shipping this year, even ...

Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

HOSPITALS in England have been hit by a surge of a “highly infectious” winter vomiting bug – and experts have warned you can ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all been flattened by an awful stomach bug at some point in our lives. For ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.